H

Huons Co Ltd
KOSDAQ:243070

Watchlist Manager
Huons Co Ltd
KOSDAQ:243070
Watchlist
Price: 26 750 KRW 0.75% Market Closed
Market Cap: 320.5B KRW

Relative Value

The Relative Value of one Huons Co Ltd stock under the Base Case scenario is 44 221.02 KRW. Compared to the current market price of 26 750 KRW, Huons Co Ltd is Undervalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
44 221.02 KRW
Undervaluation 40%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
82
Median 3Y
0.7
Median 5Y
0.9
Industry
2.4
Forward
0.5
vs History
58
vs Industry
38
Median 3Y
10.8
Median 5Y
11.2
Industry
20.3
Forward
5.5
vs History
82
vs Industry
46
Median 3Y
8.3
Median 5Y
9.3
Industry
15.6
vs History
30
vs Industry
26
Median 3Y
13.7
Median 5Y
12.6
Industry
23.1
vs History
90
vs Industry
63
Median 3Y
1.3
Median 5Y
1.5
Industry
2
vs History
90
vs Industry
81
Median 3Y
0.8
Median 5Y
0.8
Industry
2.5
Forward
0.5
vs History
82
vs Industry
79
Median 3Y
1.4
Median 5Y
1.6
Industry
4.8
vs History
74
vs Industry
43
Median 3Y
6.3
Median 5Y
6.9
Industry
12.5
Forward
4.1
vs History
47
vs Industry
39
Median 3Y
9.1
Median 5Y
9.4
Industry
15.7
Forward
5.6
vs History
80
vs Industry
44
Median 3Y
7.8
Median 5Y
9.1
Industry
14.1
vs History
vs Industry
3
Median 3Y
-11.4
Median 5Y
36.1
Industry
17.6
vs History
90
vs Industry
67
Median 3Y
1
Median 5Y
1.1
Industry
1.8

Multiples Across Competitors

Competitors Multiples
Huons Co Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Huons Co Ltd
KOSDAQ:243070
315.9B KRW 0.5 10.7 6.3 9.6
US
Eli Lilly and Co
NYSE:LLY
720.3B USD 14.6 64.6 34.9 38.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
375.8B USD 4.2 17.2 12.6 16.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.6 18.9 12.5 14.2
CH
Roche Holding AG
SIX:ROG
206.7B CHF 3.4 25 9.4 11
CH
Novartis AG
SIX:NOVN
178.5B CHF 4.1 16.8 10 13.4
UK
AstraZeneca PLC
LSE:AZN
157.1B GBP 3.8 26.9 130.3 196.4
US
Merck & Co Inc
NYSE:MRK
197.4B USD 3.1 11.3 8.1 9.8
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
US
Pfizer Inc
NYSE:PFE
130.3B USD 2.1 16.5 7.2 10.1
P/E Multiple
Earnings Growth PEG
KR
H
Huons Co Ltd
KOSDAQ:243070
Average P/E: 23.1
10.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
64.6
49%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.2
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
18.9
18%
1
CH
Roche Holding AG
SIX:ROG
25
32%
0.8
CH
Novartis AG
SIX:NOVN
16.8
17%
1
UK
AstraZeneca PLC
LSE:AZN
26.9
36%
0.7
US
Merck & Co Inc
NYSE:MRK
11.3
18%
0.6
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
16.5
29%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
H
Huons Co Ltd
KOSDAQ:243070
Average EV/EBITDA: 394.4
6.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
34.9
31%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.6
8%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
12.5
14%
0.9
CH
Roche Holding AG
SIX:ROG
9.4
6%
1.6
CH
Novartis AG
SIX:NOVN
10
5%
2
UK
AstraZeneca PLC
LSE:AZN
130.3
9%
14.5
US
Merck & Co Inc
NYSE:MRK
8.1
9%
0.9
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.2
2%
3.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
H
Huons Co Ltd
KOSDAQ:243070
Average EV/EBIT: 1 697.9
9.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.1
33%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.5
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.2
14%
1
CH
Roche Holding AG
SIX:ROG
11
6%
1.8
CH
Novartis AG
SIX:NOVN
13.4
10%
1.3
UK
AstraZeneca PLC
LSE:AZN
196.4
21%
9.4
US
Merck & Co Inc
NYSE:MRK
9.8
12%
0.8
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
10%
1